Caveat: Clinical Use Cases Will Have More Exposure Than Back Office
Not all AI use cases in healthcare carry the same risk. Back-office functions like supply chain management, revenue cycle automation, and provider onboarding are safer because they don’t always involve protected health information. That's one end of the spectrum.
On the other end, think about clinical decision support, predictive analytics, medical imaging, AI-assisted triage. These tools involve PHI, involve regulations, and impact patient outcomes.
Understanding where your AI tools fall on that spectrum is the first step in building a compliant strategy that holds up.
Here's a handy risk quadrant we put together.
Where the Framework Hits Healthcare
Patient-Facing AI is in the Crosshairs
The framework calls on Congress to combat AI-enabled fraud targeting vulnerable populations like seniors. At this point, that probably refers to scams, but it could broaden to AI-enabled fraud in patient portals, intake workflows, and billing communications.
Patient-facing tools, from symptom checkers to AI-assisted intake platforms to therapy management applications, sit in the highest-risk category. They’re external-facing, they handle PHI, and they have very acute patient impact. Expect standards for these use cases to get tighter.
PHI and Data Privacy are Still a Gray Area
The framework affirms that existing child privacy protections apply to AI systems, including limits on data collection for model training. That raises an obvious question for healthcare. What's coming for PHI?
HIPAA has governed patient data for decades, but it wasn't written with AI training in mind. The Administration's approach is largely to let courts sort out the harder questions around training data and fair use. For health IT leaders, that means more ambiguity. But, it’s a good reason to build AI governance policies that can withstand a range of regulatory outcomes.
Federal Preemption Could be a Relief for Multi-State Health Systems
The framework pushes for Congress to preempt state AI laws that impose undue burdens, with the goal of establishing a single national standard. If you operate across multiple states, you know what a patchwork of 50 different AI regulatory requirements would cost you. A unified federal law would simplify governance and reduce the legal review burden on every tool you deploy.
That said, states keep their authority to enforce general consumer protection laws, govern their own AI use in public services, and protect children. State-level enforcement of HIPAA-adjacent and consumer protection laws will likely stay intact.
Regulatory Sandboxes Could Accelerate Clinical AI Adoption
The Administration recommends Congress establish regulatory sandboxes for AI applications controlled environments where organizations can test AI with some regulatory flexibility before full deployment. For healthcare organizations that have stayed on the sidelines with higher-risk clinical AI tools because the regulatory pathway wasn't clear, this matters.
Leading health systems are already running internal pilots with this kind of controlled approach. If the federal government formalizes it, expect faster adoption of clinical AI tools that have otherwise faced long approval windows.
The Workforce Gap is Your Problem to Solve Now
The framework calls for AI training to be embedded in existing education and apprenticeship programs. That's a longer-term fix. In the meantime, your clinicians are spending more than two-thirds of their time on administrative tasks, and AI has potential to change that. But only if your staff knows how to use these tools well, safely, and compliantly.
Don't wait for federal guidance to start building internal AI literacy programs. The organizations that benefit most from AI-driven efficiency are the ones where clinical and administrative staff can use AI tools and critically evaluate what those tools are telling them.
What the Framework Doesn’t Answer
The framework is intentionally high-level. A few critical questions for healthcare remain open.
There's no guidance on clinical AI accountability. What happens when an AI-assisted clinical decision contributes to an adverse outcome? For now, the framework will probably defer to existing regulatory bodies and industry standards. For instance, FDA 510(k) pathways and existing clinical governance frameworks in software as a medical device (SaMD) are still the standard.
There's also no specific treatment of AI in revenue cycle management or insurance, even though algorithmic decision-making in those areas is already generating serious legal and ethical scrutiny. State-level enforcement in this space will likely continue, but a clear federal standard isn't visible yet.
Build a Strategy That Works in Any Regulatory Environment
The AI governance decisions you make in the next 12 to 24 months will either position you well when clearer rules arrive, or create significant work to undo them.
We recommend starting with lower-risk use cases. That means internal, administrative, and non-PHI. Build organizational competency and confidence there. Then expand into higher-risk clinical applications with HIPAA-compliant tooling, appropriate safeguards, and physician oversight.
AI policies are catching up to the technology. Will your hospital be ready?